-
可控性回結腸代膀胱術8例分析
...膀胱前後分別測量其腸腔的容量和內壓。雙側輸尿管採用Leadbetter黏膜下隧道法與結腸帶吻合。切除闌尾,向腔內置22號蘑菇頭尿管,在後下膜麥氏點處行迴腸外翻皮膚造口術。術後2周拔除雙側輸尿管支架管和造瘻管,待瘻口愈...
-
全去帶乙狀結腸原位可控膀胱術
...去除網膜帶和結腸膜帶,保留腸管兩側和中央結腸帶,用Leadbetter法行輸尿管與乙狀結腸吻合,乙狀結腸中央與後尿道吻合,吻合口可通過一手指,術中停留雙側輸尿管支架管,貯尿囊造瘻管,導尿管,腹腔及恥骨後負壓引流管...
-
實用泌尿外科手術彩色圖譜1
...側膀胱輸尿管返流防止術膀胱輸尿管逆流防止術(Polieano-Leadbetter)下段輸尿管再建術(Psoashitch法)下段輸尿管部分切除·迴腸輸尿管成形術輸尿管切開取石術(兩種術式)經尿道輸尿管結石碎石術(TUL)Tubeless輸尿管皮膚造口術...
-
巨輸尿管症的診斷和治療(附12例報告)
...症的首選,如治療無效,可採用輸尿管膀胱移植和Politano-Leadbetter抗返流術。Congenitalmegaureterinadults(Reportof12cases)WangQi,SunWeibing,QianZhongming,etalDeptofUrology,the2ndAffiliatedHospitalofDalianMedicalUniversity,Liaoning116023.【Abstract】ObjectiveToe...
-
1例男性尿道上裂伴完全性尿失禁手術治療體會
...不清。遊離膀胱頸部及雙側輸尿管下段,採用YoungDeesLeadbetter法,即裁剪膀胱頸及三角區縫成管形。取陰莖背側的尿道粘膜寬約1.5cm,沿兩側切開,保留基底部有充分血運,圍繞F8號多孔硅膠管同時縫成管形。術中要徹底切除...
-
經皮多枚空心拉力螺釘治療股骨頸骨折
...止內旋及過度牽引。所有病員採用連續硬膜外麻醉,閉合Leadbetter法(屈髖90°後行軸向牽引,髖關節內旋並內收。然後輕輕將肢體置於臺上。放鬆牽引,如肢體無外旋畸形即達到復位)。力求解剖復位。取大粗隆下2~6cm經皮呈“...
-
空心加壓螺紋釘治療股骨頸骨折56例分析
...股骨上端,在C型臂X線機監視下牽引復位。我們一般採用Leadbetter法復位,達到解剖復位或輕微過度復位。解剖復位是保持股骨距及內側皮質骨的連續性和完整性,股骨頭無前曲。輕微過度復位,即在正位X線上,遠骨折端稍向內...
-
低張力Roux-y腸代膀胱術13例報告
...術。於Roux-y吻合口上方1.5cm作抗返流瓣,輸尿管與結腸行Leadbetter法吻合,去腸管化做乙狀結腸儲尿囊.術後觀察電解質、酸鹼平衡和排尿情況。結果隨訪0.5~5.0年,除2例偶有發熱外,患者無腎積水,電解質和酸鹼平衡正常,無尿...
-
兒童股骨頸骨折45例治療體會
...例。麻醉方式:常見採用氯氨酮靜脈全身麻醉。術中採用Leadbetter法行復位,用跟掌試驗行初步評價復位情況,以X線機透視確認復位滿意後,於股骨大粗隆頂點下經皮向股骨頭方向穿入內固定針行內固定。克氏針及Knowels針選用1.8...
-
根治性全膀胱切除去帶乙狀結腸原位新膀胱術圍手術期併發症的防治
...取的結腸帶縱行切開3cm,粘膜下分離隧道,5/0可吸收線按Leadbetter法抗返流吻合輸尿管及儲尿囊,縫合結腸帶,支架管於儲尿囊戳孔引出。(6)3/0可吸收線縫合、封閉儲尿囊一端。置F24儲尿囊造瘻管,縫合儲尿囊另一端。於儲尿...
-
輸尿管功能性梗阻15例臨牀分析
...發性巨輸尿管,我們主張採取輸尿管剪裁整形並Pollitano-Leadbetter輸尿管膀胱再植術[4],應用此術式治療患者8例,均取得滿意療效。國外學者主張採用輸尿管摺疊術[5]加P-L抗逆流術[6],報道認爲摺疊術可良好地保護輸尿管...
-
RNA-associatedautoantigensactivateBcellsbycombinedBcellantigenreceptor/Toll-likereceptor7engagement
...oryMedicine,YaleUniversitySchoolofMedicine,NewHaven,CT06510Previousstudies(Leadbetter,E.A.,I.R.Rifkin,A.H.Hohlbaum,B.Beaudette,M.J.Shlomchik,andA.Marshak-Rothstein.2002.Nature.416:603–607;Viglianti,G.A.,C.M.Lau,T.M.Hanley,B.A.Miko,M.J.Shlomchik,andA.Marshak-Rothstein.2003.Immunity.19:837–847)est...
-
女性全去帶乙狀結腸原位可控性膀胱術後併發症的預防及處理(附7例報告)
...與雙側輸尿管及尿道吻合,剔除全部網膜帶和獨立帶。用Leadbetter法行輸尿管與乙狀結腸吻合(粘膜下隧道式抗反流),注意抗反流段的長度一般不少於3cm,並留置8F硅膠管作雙輸尿管內支架管,內支架管經過膀胱引流尿液到體外...
-
Antiviraldefense:interferonsandbeyond
...opmentandprogrammedcelldeath.Annu.Rev.Immunol.23:853–875.Rifkin,I.R.,E.A.Leadbetter,L.Busconi,G.Viglianti,andA.Marshak-Rothstein.2005.Toll-likereceptors,endogenousligands,andsystemicautoimmunedisease.Immunol.Rev.204:27–42.Leadbetter,E.A.,I.R.Rifkin,A.M.Hohlbaum,B.C.Beaudette,M.J.Shlomchik,andA.M...
-
MolecularIdentificationofCapnocytophagaspp.via16SrRNAPCR-RestrictionFragmentLengthPolymorphismAnalysis
....,Capnocytophagaspp.,andspirochetesoforalorigin.J.Clin.Microbiol.15:97-102.Leadbetter,E.R.,S.C.Holt,andS.S.Socransky.1979.Capnocytophaga:newgenusofGram-negativeglidingbacteria.I.Generalcharacteristics,taxonomicconsiderationsandsignificance.Arch.Microbiol.122:9-16.Mahrer,S.,andE.Raik.1992.Capnocytoph...
-
NucleicacidsofmammalianorigincanactasendogenousligandsforToll-likereceptorsandmaypromotesystemiclupuserythematosus
...latingcytokine-driveninflammationImmunol.Rev.202:250–265.Rifkin,I.R.,E.A.Leadbetter,L.Busconi,G.Viglianti,andA.Marshak-Rothstein.2005.Toll-likereceptors,endogenousligands,andsystemicautoimmunedisease.Immunol.Rev.204:27–42.Smiley,S.T.,J.A.King,andW.W.Hancock.2001.Fibrinogenstimulatesmacrophageche...
-
Balancingdiversityandtolerance:lessonsfrompatientswithsystemiclupuserythematosus
...yBcelltoleranceinpatientswithrheumatoidarthritis.J.Exp.Med.201:1659–1667.Leadbetter,E.A.,I.R.Rifkin,andA.Marshak-Rothstein.2003.Toll-likereceptorsandactivationofautoreactiveBcells.Curr.Dir.Autoimmun.6:105–122.vanEs,J.H.,F.H.GmeligMeyling,W.R.vandeAkker,H.Aanstoot,R.H.Derksen,andT.Logtenberg.1991...
-
AllisnotToll:newpathwaysinDNArecognition
...fnucleosidemodificationandtheevolutionaryoriginofRNA.Immunity.23:165–175.Leadbetter,E.A.,I.R.Rifkin,A.M.Hohlbaum,B.C.Beaudette,M.J.Shlomchik,andA.Marshak-Rothstein.2002.Chromatin-IgGcomplexesactivateBcellsbydualengagementofIgMandToll-likereceptors.Nature.416:603–607.Boule,M.W.,C.Broughton,F.Mack...
-
AutoantibodiesmakeaU-turn:thetollhypothesisforautoantibodyspecificity
...nsmallnuclearRNAsinvolvesToll-likereceptors7and8.J.Exp.Med.202:1575–1585.Leadbetter,E.A.,I.R.Rifkin,A.M.Hohlbaum,B.C.Beaudette,M.J.Shlomchik,andA.Marshak-Rothstein.2002.Chromatin-IgGcomplexesactivateBcellsbydualengagementofIgMandToll-likereceptors.Nature.416:603–607.Boule,M.W.,C.Broughton,F.Mack...
-
Dendriticcellmaturationbyinnatelymphocytes:coordinatedstimulationofinnateandadaptiveimmunity
...ofNKcellstolymphnodesprovidesIFN-forT(H)1priming.Nat.Immunol.5:1260–1265.Leadbetter,E.A.,I.R.Rifkin,A.M.Hohlbaum,B.C.Beaudette,M.J.Shlomchik,andA.Marshak-Rothstein.2002.Chromatin-IgGcomplexesactivateBcellsbydualengagementofIgMandToll-likereceptors.Nature.416:603–607.Nieda,M.,M.Okai,A.Tazbirkova,...
-
Toll-likereceptor9controlsanti-DNAautoantibodyproductioninmurinelupus
...innaiveBcellsandconstitutiveexpressioninmemoryBcells.Blood.101:4500–4504.Leadbetter,E.A.,I.R.Rifkin,A.M.Hohlbaum,B.C.Beaudette,M.J.Shlomchik,andA.Marshak-Rothstein.2002.Chromatin-IgGcomplexesactivateBcellsbydualengagementofIgMandToll-likereceptors.Nature.416:603–607.Viglianti,G.A.,C.M.Lau,T.M.Ha...
-
Toll-likereceptor–independentgeneinductionprogramactivatedbymammalianDNAescapedfromapoptoticDNAdegradation
...ticcellsviaTLR9-dependentand-independentpathways.J.Immunol.174:6129–6136.Leadbetter,E.A.,I.R.Rifkin,A.M.Hohlbaum,B.C.Beaudette,M.J.Shlomchik,andA.Marshak-Rothstein.2002.Chromatin-IgGcomplexesactivateBcellsbydualengagementofIgMandToll-likereceptors.Nature.416:603–607.Boule,M.W.,C.Broughton,F.Mack...
-
TLR9/MyD88signalingisrequiredforclassswitchingtopathogenicIgG2aand2bautoantibodiesinSLE
...7:6670–6675.Kotzin,B.L.1996.Systemiclupuserythematosus.Cell.85:303–306.Leadbetter,E.A.,I.R.Rifkin,A.M.Hohlbaum,B.C.Beaudette,M.J.Shlomchik,andA.Marshak-Rothstein.2002.Chromatin-IgGcomplexesactivateBcellsbydualengagementofIgMandToll-likereceptors.Nature.416:603–607.Christensen,S.R.,M.Kashgarian...
-
DefectiveBcelltolerancecheckpointsinsystemiclupuserythematosus
...alimmunoglobulinMantibodiesandcomplementactivation.J.Exp.Med.196:655–665.Leadbetter,E.A.,I.R.Rifkin,A.M.Hohlbaum,B.C.Beaudette,M.J.Shlomchik,andA.Marshak-Rothstein.2002.Chromatin-IgGcomplexesactivateBcellsbydualengagementofIgMandToll-likereceptors.Nature.416:603–607.Viglianti,G.A.,C.M.Lau,T.M.Ha...
-
ImpairedearlyBcelltoleranceinpatientswithrheumatoidarthritis
...teredBcelldifferentiationwithSjogren‘ssyndrome.J.Clin.Invest.109:59–68.Leadbetter,E.A.,I.R.Rifkin,A.M.Hohlbaum,B.C.Beaudette,M.J.Shlomchik,andA.Marshak-Rothstein.2002.Chromatin-IgGcomplexesactivateBcellsbydualengagementofIgMandToll-likereceptors.Nature.416:603–607.Viglianti,G.A.,C.M.Lau,T.M.Ha...
-
InnateimmunitymediatedbyTLR9modulatespathogenicityinananimalmodelofmultiplesclerosis
...tructionofTcellsdoesnotdependonantigenrecognition.Am.J.Pathol.153::715-724.Leadbetter,E.A.etal.2002..Chromatin-IgGcomplexesactivateBcellsbydualengagementofIgMandToll-likereceptors.Nature.416::603-607.Kerfoot,S.M.etal.2004..TLR4contributestodisease-inducingmechanismsresultingincentralnervoussystemaut...
-
手術室醫院信息系統的建立與應用體會
【摘要】目的建立手術室醫院信息系統(HIS),以保證圍手術期患者管理和手術部的安全運轉,達到信息及時準確傳遞及手術相關的統計工作的目的。方法在醫院信息系統運行中逐步優化和完善手術申請、手術安排、手術登記、手...
-
優化手術室業務流程提升手術檯利用率
【摘要】 目的找出目前手術室工作的流程中存在的問題,根據問題優化手術室工作流程,提高工作效率。方法運用業務流程再造的技術和方法,對原有的第一臺手術不能按時開始、連臺手術間隔時間太長等不合理的工作流程...
-
接臺手術的護理問題及對策分析
【摘要】探討手術室接臺手術中存在的護理問題,加強接臺手術中的護理。根據所存在的護理問題,進行相應的對策分析,確保手術患者的安全。【關鍵詞】接臺手術;護理問題;對策分析隨着手術量的不斷增加,手術室手術的接...
-
圍手術期手術指徵與手術適應證評價控制手術併發症降低手術風險
隨着醫學水平的不斷髮展和提高,近年來對圍手術期併發疾病的認識與處理,被認爲是提高手術治癒率、控制手術併發症、改善患者生存質量、降低圍手術期病死率及手術風險的重要因素,越來越被重視。尤其是對多學科共同協...